29 related articles for article (PubMed ID: 6308599)
1. Changes in platelet alpha 2-adrenoceptors in human phaeochromocytoma.
Brodde OE; Bock KD
Eur J Clin Pharmacol; 1984; 26(2):265-7. PubMed ID: 6327317
[TBL] [Abstract][Full Text] [Related]
2. [Disordered alpha 2-adrenoreceptor function in hemodialysis patients with renal anemia--a possible cause of increased blood pressure in relation to recombinant human erythropoietin?].
Müller R; Steffen HM; Brunner R; Pollok M; Baldamus CA; Kaufmann W
Klin Wochenschr; 1991 Oct; 69(16):742-8. PubMed ID: 1662322
[TBL] [Abstract][Full Text] [Related]
3. [Effect of erythropoietin therapy on alpha receptor density in chronic dialysis patients].
Fritschka E; Neumayer HH; Seddighi S; Distler A; Philipp T
Med Klin (Munich); 1991 Jul; 86(7):353-9. PubMed ID: 1656181
[TBL] [Abstract][Full Text] [Related]
4. Age-dependent decrease of alpha 2-adrenergic receptor number in human platelets.
Brodde OE; Anlauf M; Graben N; Bock KD
Eur J Pharmacol; 1982 Jul; 81(2):345-7. PubMed ID: 6288410
[TBL] [Abstract][Full Text] [Related]
5. Sympathetic hyperactivity in haemodialysis patients is reduced by short daily haemodialysis.
Zilch O; Vos PF; Oey PL; Cramer MJ; Ligtenberg G; Koomans HA; Blankestijn PJ
J Hypertens; 2007 Jun; 25(6):1285-9. PubMed ID: 17563543
[TBL] [Abstract][Full Text] [Related]
6. Impaired regulation of alpha- and beta-adrenoceptor function in chronic renal insufficiency.
Brodde OE; Daul A
Contrib Nephrol; 1986; 50():28-35. PubMed ID: 3026728
[No Abstract] [Full Text] [Related]
7. Loss of platelet alpha 2-adrenergic receptors during simulated extracorporeal circulation: prevention with prostaglandin E1.
Wachtogel YT; Musial J; Jenkin B; Niewiarowski S; Edmunds LH; Colman RW
J Lab Clin Med; 1985 May; 105(5):601-7. PubMed ID: 4039346
[TBL] [Abstract][Full Text] [Related]
8. Decreased number of alpha-adrenergic receptors in platelets of patients on maintenance haemodialysis.
Brodde OE; Daul A; Graben N
Proc Eur Dial Transplant Assoc; 1983; 19():270-4. PubMed ID: 6308599
[TBL] [Abstract][Full Text] [Related]
9. Adrenergic receptors in man: direct identification, physiologic regulation, and clinical alterations.
Motulsky HJ; Insel PA
N Engl J Med; 1982 Jul; 307(1):18-29. PubMed ID: 6123082
[No Abstract] [Full Text] [Related]
10. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
Brandi L
Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
[TBL] [Abstract][Full Text] [Related]
11. [Prospects for using formed elements in the blood as an extracerebral model for the study of receptors in the central nervous system (review)].
Zozulia AA
Zh Nevropatol Psikhiatr Im S S Korsakova; 1986; 86(4):599-603. PubMed ID: 3012913
[No Abstract] [Full Text] [Related]
12. [Labelling of alpha-adrenergic receptors (author's transl)].
Nishikori K
Seikagaku; 1978 Jul; 50(7):490-5. PubMed ID: 213508
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
